Literature DB >> 30118175

Operative time and cost variability for functional endoscopic sinus surgery.

Andrew J Thomas1, Kristine A Smith1, Christopher I Newberry1, Brandon Cardon1, Brock Davis1, Zhining Ou2, Angela P Presson2, Jeremy D Meier1, Jeremiah A Alt1.   

Abstract

BACKGROUND: Understanding the variation in costs of endoscopic sinus surgery (ESS) is critical to defining value. Current published costs of ESS have not identified potential sources of variation. Our objective was to analyze ESS costs to identify sources of variance that could guide value-improving decisions.
METHODS: ESS cases (n = 1739) performed between 2008 and 2016 were identified from a database of 22 rural to tertiary facilities. Cost and time data were extracted from the database. Medical records were reviewed to confirm procedures. Three bilateral groupings were examined (n = 895 cases from 13 facilities): (1) full ESS (all sinuses); (2) intermediate ESS (total ethmoid, maxillary); and (3) anterior ESS (anterior ethmoid, maxillary). Cost and operative time were analyzed using multivariable gamma regression.
RESULTS: Median costs for full, intermediate, and anterior ESS were $4281, $3716, and $2549 U.S. dollars (p < 0.001). Median durations were 87, 60, and 58 minutes (p < 0.001). Among patients with no additional procedures, those with full ESS had operative duration, total cost, and supply costs that were 1.37 (95% confidence interval [CI], 1.17 to 1.61), 1.52 (95% CI, 1.32 to 1.75), and 2.40 (95% CI, 1.76 to 3.25) times greater than anterior ESS, respectively (all p < 0.001). Intermediate ESS duration at community urban facilities was 1.87 (95% CI, 1.74 to 2.02) times that of community rural facilities (p < 0.001).
CONCLUSION: Duration of surgery, extent of surgery, and location of surgery are sources of significant variation in the cost of ESS. These findings will assist healthcare policy makers, hospitals, and surgeons in optimizing the value of ESS.
© 2018 ARS-AAOA, LLC.

Entities:  

Keywords:  clinical practice variation; delivery of health care; health care costs; health care reform; sinus surgery

Mesh:

Year:  2018        PMID: 30118175      PMCID: PMC6318025          DOI: 10.1002/alr.22198

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  22 in total

1.  A strategy for health care reform--toward a value-based system.

Authors:  Michael E Porter
Journal:  N Engl J Med       Date:  2009-06-03       Impact factor: 91.245

2.  Cost of outpatient endoscopic sinus surgery from the perspective of the Canadian government: a time-driven activity-based costing approach.

Authors:  Jennifer Au; Luke Rudmik
Journal:  Int Forum Allergy Rhinol       Date:  2013-05-23       Impact factor: 3.858

Review 3.  Medical therapy, refractory chronic rhinosinusitis, and productivity costs.

Authors:  Kristine A Smith; Luke Rudmik
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-02

4.  Concurrent septoplasty during endoscopic sinus surgery for chronic rhinosinusitis: does it confound outcomes assessment?

Authors:  Luke Rudmik; Jess Mace; Berrylin J Ferguson; Timothy L Smith
Journal:  Laryngoscope       Date:  2011-10-27       Impact factor: 3.325

5.  Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis.

Authors:  Luke Rudmik; Zachary M Soler; Jess C Mace; Rodney J Schlosser; Timothy L Smith
Journal:  Laryngoscope       Date:  2014-09-03       Impact factor: 3.325

Review 6.  Economics of Chronic Rhinosinusitis.

Authors:  Luke Rudmik
Journal:  Curr Allergy Asthma Rep       Date:  2017-04       Impact factor: 4.806

7.  Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis.

Authors:  Luke Rudmik; Timothy L Smith; Jess C Mace; Rodney J Schlosser; Peter H Hwang; Zachary M Soler
Journal:  Laryngoscope       Date:  2015-09-15       Impact factor: 3.325

Review 8.  Surgical therapy vs continued medical therapy for medically refractory chronic rhinosinusitis: a systematic review and meta-analysis.

Authors:  Zara M Patel; Andrew Thamboo; Luke Rudmik; Jayakar V Nayak; Timothy L Smith; Peter H Hwang
Journal:  Int Forum Allergy Rhinol       Date:  2016-11-11       Impact factor: 3.858

9.  Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis.

Authors:  George A Scangas; Aaron K Remenschneider; Brooke M Su; Mark G Shrime; Ralph Metson
Journal:  Laryngoscope       Date:  2016-07-21       Impact factor: 3.325

10.  Long-term utility outcomes in patients undergoing endoscopic sinus surgery.

Authors:  Luke Rudmik; Jess Mace; Zachary M Soler; Timothy L Smith
Journal:  Laryngoscope       Date:  2013-05-13       Impact factor: 3.325

View more
  2 in total

1.  Factors Affecting the Control of Chronic Rhinosinusitis With Nasal Polyps: A Comparison in Patients With or Without NERD.

Authors:  Markus Jukka Lilja; Anni Koskinen; Paula Virkkula; Seija Inkeri Vento; Jyri Myller; Sari Hammarén-Malmi; Anu Laulajainen-Hongisto; Maija Hytönen; Antti Mäkitie; Jura Numminen; Saara Sillanpää; Hannu Raitiola; Markus Rautiainen; Sanna Katriina Toppila-Salmi
Journal:  Allergy Rhinol (Providence)       Date:  2021-04-26

Review 2.  The value of endoscopic sinus surgery in chronic rhinosinusitis.

Authors:  Michael T Yim; Kristine A Smith; Jeremiah A Alt; Richard R Orlandi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-01-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.